BioCentury
ARTICLE | Analyst Picks & Changes

Analyst picks & changes

July 18, 1994 7:00 AM UTC

Procyte Corp. (PRCY)

Charles Noland of Dakin Securities repeated a "strong buy" on PRCY at under $15, saying there is no reason for the company's recent price weakness. At a $117 million market cap, he said investors are getting one of the best managed companies in the field. ...